Reviva Pharmaceuticals reduces stockholder meeting quorum to 33⅓% of voting power

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Board adopted quorum reduction from majority to one-third (33⅓%) of outstanding voting stock.
Amendment effective September 26, 2025; applies to all stockholder meetings unless law or charter requires higher.
Previous Bylaws required a majority of shares entitled to vote in person or by proxy.
No other changes to the Bylaws were made.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.